Modelling haemoglobin incremental loss on chronic red blood cell transfusions

Area of Science:

• Hematology
• Biomedical Engineering
• Clinical Medicine

Background:

• Chronic transfusion therapy requires careful management of red blood cell (RBC) lifespan and removal.
• Optimizing transfusion intervals is crucial for managing patient hemoglobin (Hb) levels and iron overload.
• Current models lack accessibility for predicting outcomes in chronic transfusion scenarios.

Purpose of the Study:

• To develop and present a novel model for optimizing chronic transfusion intervals.
• To analyze the impact of RBC lifespan, initial RBC removal, and transfusion frequency on patient Hb levels.
• To quantify total iron exposure in patients undergoing chronic transfusion therapy.

Main Methods:

• Calculated Hb levels and iron exposure using Weibull residual lifespan distributions.
• Modeled two-unit RBC transfusions initiated at patient Hb of 7 g/dl.
• Varied RBC lifespans and transfusion intervals (18-90 days), and fractional effete RBC removal (Xe: 0.1-0.5).

Main Results:

• Increased fractional RBC removal (Xe) necessitates shorter transfusion intervals to maintain target Hb levels (e.g., 30 days for Xe=0.5).
• Halving RBC lifespan requires adjusted transfusion intervals/Xe pairs to achieve steady-state Hb.
• Reducing transfused RBC increment loss by 20% decreased annual transfusions by 22% and iron addition by 24%.

Conclusions:

• Fractional Hb incremental loss (Xe) significantly impacts transfusion intervals and iron introduction.
• The developed model provides a calculable framework for optimizing chronic transfusion strategies.
• Findings support informed clinical decisions to minimize transfusion frequency and iron burden.